Facing an increasingly outraged public, the leading Big Pharma lobby group is hiking its annual dues by more than 50 percent as it prepares to defend its pharmaceutical company members against lawmakers and voters who want to rein in out-of-control drug prices. Politico reported Tuesday that “PhRMA hopes to improve its public image next year and stave off any legislative …